| Metric | Value ($ M) | Q2 FY25 | Q3 FY24 |
|---|---|---|---|
| Revenue | 5.3K | 0.3% | 3.3% |
| Total Income | 5.3K | 0.3% | 3.3% |
| Expenditure | 4.4K | 1.1% | 9.1% |
| PBT | 712.00 | 10.9% | 22.8% |
| Net Profit | 342.00 | 18.8% | 27.5% |
| OPM | 16.81% | 1.19pp | 4.45pp |
| NPM | 6.47% | 1.00pp | 2.75pp |
| EPS | 3.89 | 23.1% | 21.1% |
Tenet Healthcare Reports Strong Q3 2025 Results; Raises 2025 Outlook
04 May 2026 · 4 May, 8:41 am
Summary
Tenet Healthcare Corporation announced its results for the quarter ended September 30, 2025. Net income available to common shareholders in the third quarter of 2025 was $342 million, or $3.86 per diluted share. Consolidated Adjusted EBITDA in the third quarter of 2025 increased 12.4% to $1.099 billion compared to the third quarter of 2024. The FY 2025 Adjusted EBITDA Outlook is now expected to be in the range of $4.47 billion to $4.57 billion, a $50 million increase at the midpoint. Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet, stated that the company's high acuity service line focus and operational discipline enabled them to deliver strong same store revenue growth and attractive operational performance and free cash flow in the third quarter.
Key Highlights
- 1
Net income available to common shareholders in the third quarter of 2025 was $342 million, or $3.86 per diluted share.
- 2
Adjusted diluted earnings per share increased 26.3% to $3.70 in the third quarter of 2025 compared to $2.93 in the third quarter of 2024.
- 3
Consolidated Adjusted EBITDA in the third quarter of 2025 increased 12.4% to $1.099 billion compared to the third quarter of 2024, with an Adjusted EBITDA margin of 20.8%.
- 4
Ambulatory Care Adjusted EBITDA for the third quarter of 2025 was $492 million, reflecting a 12.1% increase over the third quarter of 2024.
- 5
Net operating revenues for the third quarter of 2025 increased 3.2% to $5,289 million compared to $5,126 million in the third quarter of 2024.
- 6
The FY 2025 Adjusted EBITDA Outlook is now expected to be in the range of $4.47 billion to $4.57 billion, a $50 million increase at the midpoint.
- 7
Free cash flow for the nine months ended September 30, 2025, was $2.163 billion, compared to $1.777 billion for the same period in 2024.
Management Comments
Saum Sutaria
M.D.
"Our high acuity service line focus and operational discipline enabled us to deliver strong same store revenue growth and attractive operational performance and free cash flow in the third quarter," "We are well positioned for continued growth as we execute on our strategy in each of our markets."
Informational and educational content only. Not investment advice.